** Life sciences firm Danaher's DHR.N shares rise 2.7% to $190 premarket
** DHR posts Q1 adj. profit of $1.88 per share, beating analysts estimates of $1.64 per share, according to the data compiled by LSEG
** Company posts Q1 revenue of $5.70 billion vs estimates of $5.59 billion
** Company anticipates that Q2 revenue will grow low-single digits year-over-year
** DHR expects annual profit in the range of $7.60 to $7.75 per share vs estimates of $7.68 per share
** Company expects annual revenue to grow 3%
** Company expects incurring incremental tariff costs in 2025 of several hundred millions of dollars
** As of last close, DHR fell 19.4% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。